Preventing Clostridium difficile Infection (CDI)

Similar documents
Clostridium difficile Infection Prevention. Basics of Infection Prevention 2-Day Mini-Course 2012

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Antimicrobial Stewardship

Clostridium Difficile Primer: Disease, Risk, & Mitigation

Running head: CLOSTRIDIUM DIFFICILE 1

Surveillance of Multi-Drug Resistant Organisms

Multi-Drug Resistant Organisms (MDRO)

Preventing Clostridium difficile. July 13,

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Educational Module for Nursing Assistants in Long-term Care Facilities: Preventing and Managing Clostridium difficile Infections

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

Policy for the Management of Clostridium Difficile

Clostridium difficile infection: The Present and the Future

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Carbapenemase-Producing Enterobacteriaceae (CPE)

Healthcare-associated Infections Annual Report December 2018

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

Horizontal vs Vertical Infection Control Strategies

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Clostridium difficile

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Other Enterobacteriaceae

C Diff: The Latest Scope on

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Antibiotic Stewardship in LTC What does this mean?

Infection Control of Emerging Diseases

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Antibiotic Stewardship in the Hospital Setting

Jump Starting Antimicrobial Stewardship

CDI Management in Post-Acute Care: Part 1

Antimicrobial Mindfulness. Beata Casanas, DO FACP FIDSA Associate Professor Division of Infectious Disease USF Morsani College of Medicine

MDRO in LTCF: Forming Networks to Control the Problem

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Get Smart For Healthcare

Healthcare-associated Infections Annual Report

Clostridium Difficile Infection (CDI) Alistair McGregor Hobart Pathology Royal Hobart Hospital TIPCU

Antimicrobial Stewardship

Antibiotic Stewardship in the LTC Setting

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

Clostridium difficile Colitis

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

GASTROINTESTINAL DISEASE IN THE HEALTHCARE SETTING: CLOSTRIDIUM DIFFICILE AND NOROVIRUS

Incidence of hospital-acquired Clostridium difficile infection in patients at risk

Section 10: Antimicrobial Stewardship and Clostridium difficile Infection: A Primer for the Infection Preventionist

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care

Updates in Antimicrobial Stewardship

Antimicrobial stewardship

APIC CHAPTER PRESENTATION 7/2014

The Core Elements of Antibiotic Stewardship for Nursing Homes

Staph and MRSA Skin Infections Fact Sheet for Schools

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

Infection Control & Prevention

Overview of Infection Control and Prevention

Clostridium difficile Infection: An Update on the Current State of Prevention

Healthcare-associated Infections Annual Report March 2015

The importance of infection control in the era of multi drug resistance

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Geriatric Mental Health Partnership

Top Ten Articles Infection Prevention and Control

Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care

MDRO: Prevention in 7 Steps. Jeanette Harris MS, MSM, MT(ASCP), CIC MultiCare Health System Tacoma, Wa.

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Clostridium difficile Colitis

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Evaluating the Role of MRSA Nasal Swabs

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

Please distribute a copy of this information to each provider in your organization.

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

11-ID-10. Committee: Infectious Disease. Title: Creation of a National Campylobacteriosis Case Definition

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Antibiotic Stewardship Beyond Hospital Walls

Antimicrobial Stewardship in the Hospital Setting

Learning Objectives 6/1/18

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1

Antimicrobial Stewardship. October 2012

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antibiotic stewardship in North Carolina hospitals

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

MRSA Control : Belgian policy

Clostridium difficile Surveillance Report 2016

INFECTIOUS DISEASES STRATEGIES TO LIMIT HOSPITALIZATION,REDUCE RISK AND ADD VALUE

Why Antimicrobial Stewardship?

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Success for a MRSA Reduction Program: Role of Surveillance and Testing

Control of Multidrug-resistant Organisms in a Hospital Environment: Multidimensional Approach

Transcription:

1 Preventing Clostridium difficile Infection (CDI) All Hands on Deck to Reduce CDI Skill Nursing Facility Conference July 28, 2017 Idamae Kennedy, MPH,BSN,RN,CIC Liaison Infection Preventionist Healthcare Associated Infections Program Center for Health Care Quality California Department of Public Health

2 Learning Objectives 1. Review the evidence for the pathogenesis, epidemiology, incubation period, and transmission of CDI 2. Describe core strategies for the prevention of CDI, including Minimizing the likelihood of transmission by assuring HCW adherence to contact precautions, hand hygiene, notification and prompt isolation Ensuring removal of C difficile spores from the environment with thorough, effective cleaning Adopting antimicrobial stewardship practices that have the greatest CDI impact

3 CDI is a Substantial and Increasing Public Health Problem Clostridium difficile caused an estimated 450,000 illnesses and 29,000 deaths in the US in 2011 (CDC, 2015) 10,771 hospital-onset CDI cases reported by California hospitals in 2015 8% increase since 2011 http://www.cdph.ca.gov/programs/hai/documents/2015- HAI-in-CA-Hospitals-Annual-Report-2015.pdf

Leffler and Lamont. New Engl J Med 2015;372:1539-48. 4

5 CDI Patients Cycle Among Regional Hospitals and Long-Term Care Facilities In Orange County, 26% of CDI patients were found to be readmitted to another hospital within 12 weeks of discharge Huang, et al. Infect Contr Hosp Epidemiol. 2010;31(11):1160-1169

6 Clostridium difficile An anaerobic, gram-positive, spore-forming, toxinproducing bacillus Transmitted among humans via fecal-oral route The leading cause of antibiotic-associated colitis in hospitals and long term care facilities Severity of CDI ranges from mild to moderate diarrhea to fulminant pseudomembranous colitis Death in up to 9% of CDI cases Leffler and Lamont. New Engl J Med 2015;372:1539-48 Lessa, et al. New Engl J Med 2015;372:825-34 Laffan, et al. J Am Geriatric Soc 2006;54(7):1068-73

7 Clostridium difficile Pathogenesis 1. Ingestion of spores transmitted to patients via the hands of healthcare personnel and environment 2. Germination into growing (vegetative) form 3. Changes in lower intestinal flora due to antimicrobial use allows proliferation of C. difficile in colon 4. Toxin A & B production leads to colon damage Sunenshine et al. Cleve Clin J Med. 2006;73:187-97

8 CDI Requires a 2-Step Process The following events may occur separately and in any order, but both are required for infection to occur: 1. The C. difficile bacterium or spore must be ingested 2. The normal intestinal flora must be compromised allowing for C. difficile to establish itself and proliferate Sunenshine et al. Cleve Clin J Med. 2006;73:187-97

9 How C. difficile Spreads -1 George, a 68-year-old man, goes to the doctor's office and is diagnosed with pneumonia. He is prescribed antibiotics, drugs that put him at risk for CDI for several months. www.cdc.gov/vitalsigns/

10 How C. difficile Spreads - 2 One month later - George breaks his leg and goes to a hospital. A healthcare worker spreads C.difficile to him after forgetting to wear gloves when treating a C.difficile infected patient in the next room. www.cdc.gov/vitalsigns/

11 How C. difficile Spreads - 3 Two days later - George transfers to a rehabilitation facility for improving his leg strength and functionality. He begins to have diarrhea. He is not tested for CDI. The healthcare worker caring for George doesn't wear gloves and infects other rehab patients. www.cdc.gov/vitalsigns/

12 CDI Incubation Period is Brief Incubation period between exposure to C. difficile and occurrence of CDI has been estimated in multiple studies to be a median of 2 3 days Molecular typing suggests incubation periods are most commonly a few days to 4 weeks Increased risk of CDI can persist many weeks after cessation of predisposing antimicrobial therapy, resulting from prolonged perturbation of normal intestinal flora Cohen et al. Infect Contr Hosp Epidemiol. 2010;31(5):431-55 Walker et al. PLoS Medicine. 2012;9(2):e1001172

13 Most Community-onset CDI is Related to Prior Hospitalization In a prospective study at a university hospital, of 136 patients with CDI, 28% had onset in the community, however 87% were previously hospitalized Johal et al. Gut. 2004;53(5):673-77 In a multicenter study, the 81% of community-onset CDI was associated with a previous hospital stay Dubberke et al. Infect Contr Hosp Epidemiology. 2010;31(10):1030-7

14 Clostridium difficile is NOT a Common Inhabitant of the Healthy Adult GI Tract Only 2 7% of the healthy adult population have been found to be colonized with C. difficile Cohen et al. Infect Contr Hosp Epidemiol. 2010;31(5):431-55 Gladys et al. J Clin Microbiol. 2014;52(7):2406-9

15 C. Difficile Colonization is Common Among Healthcare Facility Patients; Increases with Prior Healthcare Exposure 10% of asymptomatic adult patients upon admission to a tertiary care hospital were positive for toxigenic C. difficile; colonized patients were significantly more likely to have had a recent hospitalization Leekha, et al. Am J Infect Contr. 2013;41(5):390-3 15% of asymptomatic adult patients upon admission to a large teaching hospital (with or without prior healthcare exposure) Alasmari, et al. Clin Infect Dis. 2014;59(2):216-222 Up to 30% of asymptomatic residents of long-term care facilities; higher in facilities with a prior CDI outbreak Laffan, et al. J Am Geriatr Soc 2006;54(7):1068-73 Ziakas, et al. PLoS One 2015;10(2),e0117195.

16 Person-to-Person Transmission Within Healthcare Facilities is Well-Documented Up to 37% of CDI resulted from in-ward patient-topatient transmission Transmissions most commonly observed during the 1 st week following the first C. difficile positive sample collected from a newly diagnosed patient Both symptomatic CDI patients and asymptomatic C.difficile-colonized patients can spread C.difficile to other patients through direct or indirect contact via hands of healthcare workers or the environment Curry, et al. Clin Infect Dis. 2013;57(8):1094-102. Walker et al. PLoS Medicine. 2012;9(2):e1001172

17 Hand Hygiene for CDI C. difficile spores are resistant to alcohol During outbreaks or in settings with hyper endemic CDI, hand hygiene with soap and water is preferred Be aware that hand hygiene adherence may decrease when soap and water is preferred Clinical studies have not found increase in CDI with alcohol-based hand hygiene products, but several did find reductions in MRSA or VRE Gloves are effective at preventing C. difficile contamination of hands Dubberke, et al. Infect Contr Hosp Epidemiol. 2014;35(6):628-645

18 A. Frequency of C. difficile contamination of skin sites of patients with CDI Bobulsky, et al. Clin Infect Dis. 2008;46:447-50

19 B. Frequency of C. difficile acquisition on sterile gloves after contact with skin sites of patients with CDI Bobulsky, et al. Clin Infect Dis. 2008;46:447-50

20 C. Typical illustration of acquisition of C. difficile on sterile gloves after contact with a CDI-affected patient s groin. Of note, the patient had showered one hour before collection of the specimen. Bobulsky, et al. Clin Infect Dis. 2008;46:447-50

21 Perform Hand Hygiene to Prevent Carriage of C. difficile spores 24% of healthcare workers who cared for a CDI patient had C.difficile spores on their hands; spores found on 44% of nursing assistants hands 19% of nurses hands 23% of physicians hands High-risk contact (i.e., exposure to fecal soiling) and at least one contact without the use of gloves were significantly associated with healthcare worker hand contamination with C.difficile spores Landelle, et al. Infect Contr Hosp Epidemiol. 2014;35(1):10-15

22

23 Environmental Cleaning and Disinfection Facilities should have clear policies on who is responsible for cleaning each equipment used by HCW Provide additional cleaning of near touch surfaces HCW disinfection of side rails, over bed tables, IV poles and touch screens Encourage removal of clutter which makes cleaning difficult Ensure dedicated non-critical, non-disposable items are cleaned and disinfected following the facility policies Clean and contaminated equipment should be clearly identified

24 Why is bleach or a disinfectant with a sporicidal claim used to clean CDI patient rooms? C. difficile spores are difficult to kill and adhere to environmental surfaces for extended periods Use of a 1:10 dilution of bleach (500 ppm) for cleaning of the environment reduces surface contamination and is instrumental in outbreak control Environmental Protection Agency (EPA) provides a list of alternate disinfectants with a label claim for killing C. difficile spores at http://www.epa.gov/oppad001/chemregindex.htm Hota. CID. 2004. CDC. MMWR. Dec 19, 2003 Rutala et al. Clinical Microbiology Review. Oct 1997 HICPAC /CDC 2008

Is there evidence that environmental cleaning with bleach can reduce CDI rates on highincidence units? 25 Mayfield et al. Clin Infect Dis. 2000

26 Why should we assess adequacy of environmental cleaning? The mean percentage of high-risk objects (HROs) determined to have been cleaned in each of 36 acute care hospitals was 48% Carling et al.iche 2008

27 Can the use of monitoring technology help improve adequacy of room cleaning? Carling. ICHE. 2008

28 Antibiotic exposure is the major risk factor for CDI when a patient is also exposed to the C. difficile bacterium or spores Increases in CDI risk are observed with increased cumulative dose, number of antibiotics, and days of antibiotic therapy Risk of CDI compared to patient on 1 antibiotic Number of antibiotics 2 3-4 5+ 2.5 times higher 3.3 times higher 9.6 times higher Risk of CDI compared to patient on antibiotics <4 days Days of antibiotics 4-7 8-18 >18 1.4 times higher 3.0 times higher 7.8 times higher Stevens, et al. Clin Infect Dis. 2011;53(1):42-48

29 Antimicrobial Stewardship Interventions to Address CDI incidence Improved overall antimicrobial prescribing Fewer patients on antimicrobials Fewer patients develop CDI Fewer CDI patients contribute to transmission Stopping unnecessary antibiotics in patients with new CDI diagnoses Improves clinical response of CDI to treatment and reduces the risk of recurrent CDI Fewer CDI patients contribute to transmission Dubberke, et al. Infect Contr Hosp Epidemiol. 2014;35(6):628-645

30 Antimicrobial stewardship targeting antimicrobials associated with CDI can reduce CDI incidence Valiquette, et al. Clin Infect Dis. 2007;45:S112-21

31 Recognize CDI Signs and Symptoms Assess for diarrhea symptoms and duration Review recent history of healthcare exposure, hospitalization, clinic visits, long term care stay, history of recent antibiotics Collect stool samples for testing that meet laboratory requirements See Bristol Stool Chart for an example of stool quality to be submitted Communicate and document test results

32 Enhance Communication Between Facilities Each facility has a key role in communicating CDI status for patients being transferred/discharged to other health care facilities Work with discharge planners and case management to communicate CDI onset, treatment, diarrhea status Provide nursing report/handoff including CDI history, date of onset, current/past treatment, diarrhea status Improve coordination to ensure patients with CDI continue appropriate treatment and that appropriate infection control precautions for CDI patients are maintained

33

Participate in Local and Regional CDI Prevention Activities 34

35 Framework for a Regional Approach to CDI Prevention A network of healthcare facilities with a shared patient population address CDI prevention across the continuum of care through: 1. Monitoring adherence to CDI prevention practices in hospitals and long-term care facilities Hand hygiene Contact precautions Inter-facility communication 2. Starting or enhancing an Antimicrobial stewardship program with particular attention to CDI 3. Performing thorough Environmental Cleaning - evaluating and enhancing

36 Regional CDI Prevention Collaborative - Objectives Strengthen Clostridium difficile infection (CDI) prevention practices in healthcare facilities Enhance communication and coordination among healthcare facilities across the continuum of care Reduce CDI in vulnerable populations and our community

37 Figure from CDC Vital Signs: http://www.cdc.gov/vitalsigns/stop-spread/index.html

38 Summary: 6 Steps to CDI Prevention 1. Prescribe and use antibiotics carefully. About 50% of all antibiotics given are not needed, unnecessarily raising the risk of CDI. 2. Test for C. difficile when patients have diarrhea while on antibiotics or within several months of taking them. 3. Isolate patients with C. difficile immediately.

39 Summary: 6 Steps to CDI Prevention (continued) 4. Wear gloves and gowns when treating patients with C. difficile, even during short visits. Hand sanitizer does not kill C. difficile, and hand washing may not be sufficient. 5. Clean room surfaces with bleach or another EPAapproved, spore-killing disinfectant after a patient with C. difficile has been treated there. 6. When a patient transfers, notify the new facility if the patient has CDI or was found to be colonized with C. difficile. CDC Vital Signs www.cdc.gov/vitalsigns/stop-spread/index.html

40 Questions? For more information, please contact The HAI Program at HAIProgram@cdph.ca.gov Thank you